Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 144, Issue 1, Pages 81-92
Publisher
Wiley
Online
2017-11-04
DOI
10.1111/jnc.14249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The blood-brain barrier and protein-mediated fatty acid uptake: role of the blood-brain barrier as a metabolic barrier
- (2017) Eric J. Murphy JOURNAL OF NEUROCHEMISTRY
- The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport
- (2017) Yusuke Ochiai et al. JOURNAL OF NEUROCHEMISTRY
- Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder
- (2016) Jingshu Xu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fatty Acid-Binding Protein 5 at the Blood–Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function
- (2016) Yijun Pan et al. JOURNAL OF NEUROSCIENCE
- Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury
- (2016) Johnny D. Figueroa et al. JOURNAL OF NEUROTRAUMA
- Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis
- (2016) Hussein N. Yassine et al. JAMA Neurology
- Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid
- (2015) Yijun Pan et al. MOLECULAR PHARMACEUTICS
- Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier
- (2015) Akihiko Urayama et al. PLoS One
- Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain
- (2015) Chuck T. Chen et al. Scientific Reports
- Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease
- (2015) J. Thomas et al. Biomed Research International
- Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
- (2015) Salma A. Abdelmagid et al. PLoS One
- Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor β/δ (PPARβ/δ) in the Brain
- (2014) Shuiliang Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
- (2014) Long N. Nguyen et al. NATURE
- Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC–MS technique
- (2013) Dharmini C. Mehta et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease
- (2013) Kenghoe Lok et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
- (2013) Dharmini C. Mehta et al. PHARMACEUTICAL RESEARCH
- Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPAR and ERK MAPK Signaling Pathways
- (2012) L. A. Denner et al. JOURNAL OF NEUROSCIENCE
- Omega-3 Polyunsaturated Fatty Acids in Alzheimers Disease: Key Questions and Partial Answers
- (2011) F. Calon Current Alzheimer Research
- Impact and Therapeutic Potential of PPARs in Alzheimers Disease
- (2011) Michael T. Heneka et al. Current Neuropharmacology
- Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models
- (2011) Yuhai Zhao et al. PLoS One
- Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid
- (2010) Hee-Yong Kim et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study
- (2009) Melissa Ouellet et al. NEUROCHEMISTRY INTERNATIONAL
- Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice
- (2009) Ainhoa Plaza-Zabala et al. SYNAPSE
- Validation of a 2-day water maze protocol in mice
- (2008) Maria Gulinello et al. BEHAVIOURAL BRAIN RESEARCH
- High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-β and tau pathologies in the 3xTg-AD model of Alzheimer's disease
- (2008) A. Phivilay et al. NEUROSCIENCE
- Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood–brain barrier
- (2008) William A. Banks et al. PEPTIDES
- Regulation of brain polyunsaturated fatty acid uptake and turnover
- (2008) Chuck T. Chen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability
- (2007) Thomas Fraser et al. JOURNAL OF NEUROSCIENCE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started